AGfit-3

Clinical Evidence
and Scientific Research
on AGfit-3

AGfit-3:

Clinical Evidence and Scientific Research on AGfit-3

Clinical studies, research and scientific publications

AGfit-3 has undergone rigorous clinical trials, particularly in partnership with the University of Padua, demonstrating significant reductions in blood alcohol levels.

The combination of Silymarin, Myrica cerifera, and Bio-PQQ not only supports faster alcohol metabolism but also acts as a potent antioxidant, protecting the liver from alcohol-induced oxidative stress.

You can review our research in top scientific journals such as Nutrients for more in-depth insights.

The global market for hangover products is booming, driven by increasing demand for natural, effective remedies. As per Straits Research, the market is expected to surpass USD 9 billion by 2033, presenting a significant opportunity for innovative solutions like AGfit-3.

Discover the university study

Alchimia Innovazione SRL

Sede
VIALE DELLA NAVIGAZIONE INTERNA 51
35129 PADOVA

Laboratorio
VIA ENRICO MATTEI, 2
31030 DOSSON DI CASIER (TV)

Contacts

info@alchimiainnovazione.it 
PEC alchimia.innovazione@pec.it
P. IVA 05260200281

info@agfit3.com

For Informations

Raffaele Papa
Tel. +39 375 5491707
raffaele.papa@agfit3.com

Roberto Brusadin
Tel. +39 348 3119082

 

Torna in alto